Sign in
CompletedPhase 4

Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.

Key facts

Who runs it
Jesús María Villar del Moral
Where
Spain21 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
184 people enrolled
Started
25 Nov 2019
Ended
30 Nov 2023
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Lugols Strong Iodine
Record updated
6 March 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Patients who meet all of the following criteria will be eligible:
  • The age of the patient must be over 18 years of age
  • The patient or his / her tutor, in cases where this is the case, has the capacity to understand the study and agrees to participate in it, by signing the corresponding informed consent document
  • Patients who have been diagnosed with GD, defined as the existence of hyperthyroidism (TSH < lower limit of laboratory normality associated with TSI > upper limit of laboratory normality) that present ultrasonographic data (diffuse vascularization increase) and / or scintigraphy (diffuse uptake of the radioisotope) compatible with GD
  • Euthyroid patients (free T4 and / or free T3 within the normal range of the laboratory) at the time of randomization, and under treatment with AT drugs (propylthiouracil, carbimazole or methimazole)
  • The patient must be proposed for total thyroidectomy, using a transcervical approach

Who cannot take part

  • Prior cervicotomy by surgical intervention on the thyroid or parathyroid gland
  • Associated hyperparathyroidism that requires associating a parathyroidectomy in the same surgical act
  • Surgery performed by training specialists, or by staff not specifically dedicated to endocrine surgery
  • Surgery not performed under general anesthesia
  • Endoscopic surgery, video assisted or by remote approach
  • Surgery performed in out-patient settings
  • Current drug consumption or alcohol abuse that could interfere with meeting the study requirements
  • Participation in any other trial with medications in the month prior to randomization
  • Associated thyroid cancer that requires adding a lymph node dissection of the central or lateral compartment in the same surgical time
  • Iodine allergy
  • The participant can not participate in the study if he / she presents any of the following circumstances:
  • Consumption of lithium or amiodarone between randomization and administration of LS
  • Patients with category IV of the anesthetic risk classification of the American Society of Anesthesiologists (ASA)
  • Women who breastfeed during the administration of the LS or in the month after it
  • Preoperative palsy of a vocal cord verified by laryngoscopy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Currently, both the American Thyroid Association and the European Thyroid Association recommend the use of Lugol Solution (LS) in the preparation of patients undergoing thyroidectomy for Graves' disease (GD), but their recommendations are based on a low level of evidence. This means that its use is not generalized among the different endocrine surgery units.

Read full original descriptionShow less

Methods:

Study population: 270 patients (135 patients in each arms) undergoing total thyroidectomy (TT) due to GD in Spanish hospitals, which perform a minimum of 100 thyroidectomies a year, at least 10 of them for GD.

Variables:

Preoperative variables

* Demographic variables: birthdate, gender and ethnicity. * Drugs allergies. Allergy to iodine. * Personal history and usual treatment. * Aspects related to the GD: date of diagnosis, use of AT drugs and/or radioiodine, existence of ophthalmopathy, existence of cervical compression symptoms and indication of surgery. * Physical exploration: body mass index, pulse at rest and blood pressure and cervical palpation. * Laboratory tests: hematocrit, leukocytes, neutrophils, platelets, international normalized ratio(INR), creatinine, potassium, total calcium, albumin, total proteins, parathormone (PTH), 25-hydroxide-vitamin D, free T4 and / or free T3, TSH, thyroid stimulating immunoglobulin (TSI). * Classification of the anesthetic risk of ASA. * Cervical ultrasound: existence of thyroid nodules and volume of the thyroid. * Mobility of the vocal cords evaluated by laryngoscopy. * Compliance with assigned treatment: the patient assigned to the LS arm must have consumed at least 80% of the total dose indicated.

Intraoperative variables

* Surgical time. * Antibiotic prophylaxis * Intraoperative hemorrhage. * Thyroidectomy Difficulty Scale. * Loss of electromyographic signal during neural intraoperative monitorization. * Accidental parathyroidectomy. * Section or obvious lesion of the recurrent laryngeal nerve. * Trachea or esophagus perforation. * Weight of the gland. * Electrosurgical hemostasis system used during the intervention. * Maneuvers used to check hemostasis. * Hemostats used during the intervention. * Use of drainage. * Definitive surgical technique: TT, unilateral or bilateral subtotal thyroidectomy or hemithyroidectomy.

Postoperative variables

* Early complications: hypoparathyroidism, paralysis of the recurrent laryngeal nerve, postoperative hematoma, surgical site infection or death. * Debit for surgical drains. * Postoperative hospital long of stay. * Anatomopathological variables: histological diagnosis compatible with GD and existence of parathyroid glands in the surgical specimen. * Long-term complications: hypocalcemia and/or permanent vocal cord paralysis longer than 6 months

The 2 groups in the trial

  • Preoperative Lugol Solution preparationTreatment being tested

    Patients will receive Lugol Solution preparation for 10 days before thyroidectomy

    Treatment: Lugols Strong Iodine

  • No preparationNo study treatment, for comparison

    Patients will not receive preparation before thyroidectomy

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Clinical Trial, Blinded for the Researcher and Multicenter, to Evaluate the Efficacy and Safety of Preoperative Preparation With Lugol Solution in Euthyroid Patients With Graves-Basedow Disease.
Publications
Record updated
6 March 2024